← Browse by Condition
Medical Condition
gastroenteropancreatic neuroendocrine tumor
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 4
NCT05701241 Phase 4
Recruiting
Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients
Enrollment
270 pts
Location
Belgium, Netherlands
Sponsor
University Hospital, Antwerp
NCT04090034
Recruiting
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Enrollment
50 pts
Location
United States
Sponsor
Methodist Health System
NCT06256705
Recruiting
Multi-modal Characterisation of Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETs) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort
Enrollment
80 pts
Location
France
Sponsor
Assistance Publique - Hôpitaux...
NCT06155318
Recruiting
68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours
Enrollment
300 pts
Location
Italy
Sponsor
IRCCS San Raffaele